Strattera and Skin disorder - a phase IV clinical study of FDA data

Summary:

Skin disorder is reported as a side effect among people who take Strattera (atomoxetine hydrochloride), especially for people who are male, 10-19 old, have been taking the drug for < 1 month also take Prilosec, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Skin disorder when taking Strattera. It is created by eHealthMe based on reports of 27,428 people who have side effects when taking Strattera from the FDA, and is updated regularly.

What is Strattera?

Strattera has active ingredients of atomoxetine hydrochloride. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 29,323 Strattera users. Check the latest studies of Strattera.

What is Skin disorder?

Skin disorder (skin disease) is found to be associated with 1,545 drugs and 1,449 conditions by eHealthMe. Check the latest studies of Skin disorder.

On Jul, 15, 2026

27,428 people reported to have side effects when taking Strattera.
Among them, 19 people (0.07%) have Skin disorder.

Among these 19 people:

How long have people been on Strattera when they have Skin disorder? *

What is the gender of people who have Skin disorder when taking Strattera? *

female: 35.29 %
male: 64.71 %

What is the age of people who have Skin disorder when taking Strattera? *

What are other drugs people take besides Strattera? *

What are other side effects people have besides Skin disorder? *

Itching: 3 people, 15.79%
Stress And Anxiety: 3 people, 15.79%
Rashes (redness): 3 people, 15.79%
Chills (felling of cold): 2 people, 10.53%
Gait Disturbance: 2 people, 10.53%
Joint Pain: 2 people, 10.53%
Pain In Extremity: 2 people, 10.53%
Peripheral Swelling: 2 people, 10.53%
Weakness: 2 people, 10.53%
Suicide Attempt: 1 person, 5.26%

What are the existing conditions these people have? *

High Blood Cholesterol: 2 people, 10.53%
Stress And Anxiety: 2 people, 10.53%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 2 people, 10.53%
Herpes Zoster: 1 person, 5.26%
Acne Cystic (skin problems that cause pimples): 1 person, 5.26%
Bipolar Disorder (mood disorder): 1 person, 5.26%
Blood Glucose Abnormal: 1 person, 5.26%
Cardiac Disorder: 1 person, 5.26%
Chest Pain: 1 person, 5.26%
Dizziness: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Strattera and have Skin disorder?

- Check whether Skin disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Strattera:

Strattera (29,323 reports)

Skin disorder treatments and more:

Skin disorder (41,532 reports)

Browse all side effects of Strattera:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Skin disorder:

Skin disorder (1,545 drugs)

Browse all the conditions that are associated with Skin disorder:

Skin disorder (1,449 conditions)

Related publications that referenced our studies

Moftah NH, Kamel AM, Attia HM, El-Baz MZ, El–Moty HM, "Skin diseases in patients with primary psychiatric conditions: a hospital based study", Journal of epidemiology and global health, 2013 Sep .
Moftah NH, Kamel AM, Attia HM, El-Baz MZ, El–Moty HM, "Skin diseases in patients with primary psychiatric conditions: a hospital based study", Journal of epidemiology and global health, 2013 Sep .

How the study uses the data?

The study uses data from the FDA. It is based on atomoxetine hydrochloride (the active ingredients of Strattera) and Strattera (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.